Avatar

Hi, Im Tanner

@tannerfuckingbosch-blog / tannerfuckingbosch-blog.tumblr.com

And I don't want to live.
Avatar

"It's going to be okay."

I don't want anyone to tell me it's going to be okay. I want someone to make me feel like it's going to be okay.

Avatar

when she says she doesn’t send nudes

image

when guys objectify women and expect them to send nudes

image

when someone asks you about your nuclear plans for russia

image
Avatar
hikingnerd

When Russia sends you nudes

image
Avatar
onwardwall

This is my favorite post in all of tumblr

reminder that this post is now illegal in Russia

Avatar
A former hedge fund manager turned pharmaceutical businessman has purchased the rights to a 62-year-old drug used for treating life-threatening parasitic infections and raised the price overnight from $13.50 per tablet to $750.
According to the New York Times, Martin Shkreli, 32, the founder and chief executive of Turing Pharmaceuticals, purchased the rights to Daraprim for $55 million on the same day that Turing announced it had raised $90 million from Shkreli and other investors in its first round of financing.
Daraprim is used for treating toxoplasmosis — an opportunistic parasitic infection that can cause serious or even life-threatening problems in babies and for people with compromised immune systems like AIDS patients and certain cancer patients — that sold for slightly over $1 a tablet several years ago.  Prices have increased as the rights to the drug have been passed from one pharmaceutical company to the next, but nothing like the almost 5,500 percent increase since Shkreli acquired it.

This is absolutely monstrous. He’s like a parody of a capitalist from a Marxist propaganda film. Jesus H. Christ what a piece of trash.

Spread his face around. Don’t let him be anonymous. Let everyone know his name and what he looks like so that he’ll never, ever be able to go about in public again without being utterly terrified.

dear god

You are using an unsupported browser and things might not work as intended. Please make sure you're using the latest version of Chrome, Firefox, Safari, or Edge.